# Ranibizumab

## Lucentis inj 10mg/mL， 0.165mL

#### 一般可用

| 藥品代碼       | ILUC3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:---------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Diabetic macular edema: Treatment of diabetic macular edema (DME). Diabetic retinopathy: Treatment of diabetic retinopathy Macular degeneration: Treatment of neovascular (wet) age-related macular degeneration (AMD) Macular edema: Treatment of macular edema following retinal vein occlusion (RVO) Myopic choroidal neovascularization: Treatment of myopic choroidal neovascularization (mCNV).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 用法用量       | 0.5mg via IVIA. The second injections into the same eyeball must be at least 4 weeks apart. The initial treatment may require 3 months or longer until no vision and/or anatomy in patient with wet type (Neovascular) of age-related macular degeneration (wAMD)， diabetic macular edema(DME)， retinal vein occlusion (RVO).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 禁忌           | Active or suspected ocular or periocular infections， active intraocular inflammation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 副作用         | Nasopharyngitis， influenza; anemia; anxiety; headache， stroke; intraocular inflammation， vitritis， vitreous detachment， retinal hemorrhage， visual disturbance， eye pain， vitreous floaters， conjunctival hemorrhage， eye irritation， foreign body sensation in eyes， lacrimation increased， blepharitis， dry eye， ocular hyperemia， eye pruritus; retinal degeneration， retinal disorder， retinal detachment， retinal tear， detachment of retinal pigment epithelium， retinal pigment epithelium tear， visual acuity reduced， vitreous hemorrhage， vitreous disorder， uveitis， iritis， iridacyclitis， cataract， calaract subcapsular， posterior capsule opacification， punctuate keratitis， corneal abrasion， anterior chamber flare， vision blurred， inj site hemorrhage， eye hemorrhage， conjunctivitis， conjunctivitis allergic， eye discharge， photopsia， photophobia， ocular discomfort， eyelid edema， eyelid pain， conjunctival hyperemia; cough; nausea; allergic reactions; arthralgia; intraocular pressure increased. Common Ophthalmic: Cataract ( eovascular(wet) age-related macular degeneration 11% to 17%;macular edema following retinal vein occlusion，2%) ， conjunctival hemorrhage (neovascular (wet) age- related macular degeneration 64% to 74%; macular edema following retinal vein occlusion， 48%) ， Eye irritation (neovascular (wet) age- related macular degeneration 13% to 15% ; macular edema following retinal vein occlusion，7%) ， Foreign body sensation， in the eyes (neovascular (wet) age- related macular degeneration 13% to 16%; macular edema following retinal vein occlusion， 7% to 16%) ，Inflammatory disorder of the eye (neovascular (wet) age- related macular degeneration 13% to 18% )， Pain in eye (neovascular (wet) age- related macular degeneration 26 % to 35% ; macular edema following retinal vein occlusion， 17% )， Raised intraocular pressure (neovascular (wet) age- related macular degeneration 17% to 24% ; macular edema following retinal vein occlusion，7% ) ，Visual disturbance (neovascular (wet) age- related macular degeneration 13% to 18% ; macular edema following retinal vein occlusion，5% )， Vitreous detachment (neovascular (wet) age- related macular degeneration 15% to 21% ; macular edema following retinal vein occlusion，4% ) ， Vitreous floaters (neovascular (wet) age- related macular degeneration19 % to 27% ; macular edema following retinal vein occlusion， 7 %) |
| 孕期用藥建議   | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

